The
IBEX, Spain’s stock market index, may soon surpass its peak from March 25, 2025, before a tariff war triggered a selloff. That peak marked the end of wave I in Elliott Wave analysis. The subsequent decline, wave II, formed a zigzag pattern, as shown on the 1-hour chart. From the March 25 high, wave ((A)) dropped to 13,051.8, wave ((B)) rebounded to 13,347.3, and wave ((C)) fell to 11,570.06, completing wave II.
Since then, the
IBEX has recovered strongly, with the rally from wave II following an impulsive Elliott Wave pattern. Starting from wave II, wave 1 peaked at 12,318.8, and wave 2 dipped to 11,615.2. The index then climbed in wave 3, with sub-waves ((i)) at 12,810.8, ((ii)) at 12,158.5, ((iii)) at 13,241.2, and ((iv)) at 13,110.4. The index is expected to soon complete wave ((v)) of 3, followed by a wave 4 pullback, before rising again in wave 5 to finish wave (1).
After that, a correction in wave (2) from the April 7, 2025 low is likely before the index continues higher. In the near term, as long as the 11,570.06 low holds, any pullbacks should attract buyers in a 3, 7, or 11-swing pattern, supporting further gains.
Since then, the
After that, a correction in wave (2) from the April 7, 2025 low is likely before the index continues higher. In the near term, as long as the 11,570.06 low holds, any pullbacks should attract buyers in a 3, 7, or 11-swing pattern, supporting further gains.
14 days trial --> elliottwave-forecast.com/amember/go.php?r=2670&i=l3 and get Accurate & timely Elliott Wave Forecasts of 78 instruments. Webinars, Chat Room, Stocks/Forex/Indices Signals & more.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
14 days trial --> elliottwave-forecast.com/amember/go.php?r=2670&i=l3 and get Accurate & timely Elliott Wave Forecasts of 78 instruments. Webinars, Chat Room, Stocks/Forex/Indices Signals & more.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.